Advertisement

Topics

BRIEF-Merck CEO Kenneth Frazier on CNBC - We continue to have great hopes for our Alzheimer's drug

06:06 EST 1 Dec 2016 | Reuters

* Merck CEO Kenneth Frazier on CNBC - We continue to have great hopes for our Alzheimer's drug

Original Article: BRIEF-Merck CEO Kenneth Frazier on CNBC - We continue to have great hopes for our Alzheimer's drug

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Merck CEO Kenneth Frazier on CNBC - We continue to have great hopes for our Alzheimer's drug"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...